Position history for Chevy Chase Trust Holdings, LLC's holdings in REGENERON PHARMACEUTICALS
Chevy Chase Trust Holdings, LLC holds 200,747 shares of REGN (REGENERON PHARMACEUTICALS), worth $155M as of 2025-Q4. The position was decreased (-1.2% shares). REGN represents 0.4% of Chevy Chase Trust Holdings, LLC's portfolio.
Current Value
$155M
Current Shares
200,747
Total Value Change
-$99.1M
Total Shares Change
-41,007
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 200,747 |
-1.2% |
| $155M |
| 0.4% |
| $773.94 |
0 |
| 2025-Q3 | Decreased | 203,152 | -1.7% | $114.2M | 0.3% | $560.05 | 0 |
| 2025-Q2 | Decreased | 206,728 | -6.5% | $108.5M | 0.3% | $519.56 | 0 |
| 2025-Q1 | Decreased | 221,210 | -3.7% | $140.3M | 0.4% | $634.66 | 0 |
| 2024-Q4 | Decreased | 229,767 | -3.6% | $163.7M | 0.5% | $698.71 | 0 |
| 2024-Q3 | Decreased | 238,379 | -1.4% | $250.6M | 0.8% | $1,036.94 | 0 |
| 2024-Q2 | Decreased | 241,754 | -0.3% | $254.1M | 0.8% | $1,045.23 | 0 |